DEFERASIROX STADA 90mg tablets medication leaflet

V03AC03 deferasirox • Various | All other therapeutic products | Iron chelating agents

Deferasirox is an iron chelator used for the treatment of chronic iron overload in patients with frequent blood transfusions, such as those with major thalassemia. It works by binding excess iron, facilitating its elimination through feces.

The medication is taken orally, usually once daily, with the dose adjusted based on the body's iron levels and the patient's weight. Common side effects include nausea, diarrhea, abdominal pain, and elevated liver enzymes.

Deferasirox is contraindicated in patients with severe renal impairment, hepatic failure, or hypersensitivity to the active substance. Its use also requires regular monitoring of renal and hepatic function.

This medication is an effective option for managing iron overload, helping to prevent complications associated with this condition.

General data about DEFERASIROX STADA 90mg

Substance: deferasirox

Date of last drug list: 01-10-2020

Commercial code: W66840005

Concentration: 90mg

Pharmaceutical form: tablets

Quantity: 300

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: PHARMADOX HEALTHCARE LIMITED - MALTA

Holder: STADA M&D S.R.L. - ROMANIA

Number: 12950/2020/05

Shelf life: 3 years

Pharmaceutical forms available for deferasirox

Concentrations available for deferasirox

125mg, 180mg, 250mg, 360mg, 500mg, 90mg

Other substances similar to deferasirox